Literature DB >> 22461105

PPARα agonists--an emerging concept in the management of neuropathic and visceral pain.

Shailendra Kapoor.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22461105     DOI: 10.1007/s00213-012-2694-0

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  9 in total

1.  Multimodal stepped care approach with acupuncture and PPAR-α agonist palmitoylethanolamide in the treatment of a patient with multiple sclerosis and central neuropathic pain.

Authors:  David J Kopsky; Jan M Keppel Hesselink
Journal:  Acupunct Med       Date:  2012-02-01       Impact factor: 2.267

2.  Synergistic antinociception by the cannabinoid receptor agonist anandamide and the PPAR-alpha receptor agonist GW7647.

Authors:  Roberto Russo; Jesse LoVerme; Giovanna La Rana; Giuseppe D'Agostino; Oscar Sasso; Antonio Calignano; Daniele Piomelli
Journal:  Eur J Pharmacol       Date:  2007-03-19       Impact factor: 4.432

3.  Alteration of neuropathic and visceral pain in female C57BL/6J mice lacking the PPAR-α gene.

Authors:  Jessica Ruiz-Medina; Juan A Flores; Inmaculada Tasset; Isaac Tunez; Olga Valverde; Emilio Fernandez-Espejo
Journal:  Psychopharmacology (Berl)       Date:  2012-02-22       Impact factor: 4.530

4.  Implication of allopregnanolone in the antinociceptive effect of N-palmitoylethanolamide in acute or persistent pain.

Authors:  Oscar Sasso; Roberto Russo; Sergio Vitiello; Giuseppina Mattace Raso; Giuseppe D'Agostino; Anna Iacono; Giovanna La Rana; Monique Vallée; Salvatore Cuzzocrea; Pier Vincenzo Piazza; Rosaria Meli; Antonio Calignano
Journal:  Pain       Date:  2011-09-03       Impact factor: 6.961

5.  Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory pain.

Authors:  Maulik D Jhaveri; Denise Richardson; Ian Robinson; Michael J Garle; Annie Patel; Yan Sun; Devi R Sagar; Andrew J Bennett; Stephen P H Alexander; David A Kendall; David A Barrett; Victoria Chapman
Journal:  Neuropharmacology       Date:  2008-04-29       Impact factor: 5.250

6.  Analgesic properties of oleoylethanolamide (OEA) in visceral and inflammatory pain.

Authors:  Margarita Suardíaz; Guillermo Estivill-Torrús; Carlos Goicoechea; Ainhoa Bilbao; Fernando Rodríguez de Fonseca
Journal:  Pain       Date:  2007-04-20       Impact factor: 6.961

7.  Inhibition of fatty acid amide hydrolase produces PPAR-alpha-mediated analgesia in a rat model of inflammatory pain.

Authors:  D R Sagar; D A Kendall; V Chapman
Journal:  Br J Pharmacol       Date:  2008-08-25       Impact factor: 8.739

8.  Pioglitazone attenuates tactile allodynia and thermal hyperalgesia in mice subjected to peripheral nerve injury.

Authors:  Takehiko Maeda; Norikazu Kiguchi; Yuka Kobayashi; Masanobu Ozaki; Shiroh Kishioka
Journal:  J Pharmacol Sci       Date:  2008-11-13       Impact factor: 3.337

9.  Antinociceptive and antiedematogenic activities of fenofibrate, an agonist of PPAR alpha, and pioglitazone, an agonist of PPAR gamma.

Authors:  Antônio Carlos P Oliveira; Caryne M Bertollo; Leonardo Tadeu S Rocha; Elias B Nascimento; Karina A Costa; Márcio M Coelho
Journal:  Eur J Pharmacol       Date:  2007-01-19       Impact factor: 4.432

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.